Taipei City | Date: February 4, 2025
regeneratiYC Biotech Co., Ltd. announced recently that it will conduct an innovative animal study on hair follicle regeneration, scheduled to begin in February 2025. This nearly year-long research will evaluate the efficacy of hair follicle stem cell exosomes in promoting hair growth.
This prospective study will conduct a systematic evaluation focused on male pattern baldness. YC Biotech will utilize its expertise and experience in animal studies to establish comprehensive testing protocols, examining the effects of various exosome formulations on hair growth. The research will incorporate cutting-edge exosome technology combined with systematic trial design to explore new possibilities in hair regeneration therapy. We are honored to collaborate in advancing innovative developments in regenerative medicine.
Key research objectives include:
- Evaluating the safety profiles of different exosome formulations
- Analyzing the hair growth promotion effects of various formulations
- Establishing dose-response relationships
- Observing the sustainability of post-treatment hair growth
- Documenting comprehensive histopathological changes
This study is expected to lay a solid scientific foundation for future clinical applications. YC Biotech will capitalize on its expertise in preclinical trials to drive the development of advanced hair regeneration therapies, further reinforcing its position as a leader in biomedical research and regenerative medicine.ve medicine.